Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Mizuho Medy Co., Ltd. (4595) Price & Analysis

4595 Stock Chart & Stats

¥1,711.00¥10.00(0.59%)
At close: 4:00 PM EDT
JPY 1,650JPY 1,700JPY 1,7503 Aug17 Aug31 Aug14 Sep28 Sep13 Oct26 Oct
Day’s Range
JPY 1,696.00 - JPY 1,718.00
52-Week Range
JPY 1,597.00 - JPY 1,930.00
Previous Close
JPY 1,701.00
Volume
223.50K
Average Volume (3M)
61.85K
Market Cap
JPY 32.59B
Enterprise Value
JPY 18.35B
Total Cash (Recent Filing)
JPY 13.06B
Total Debt (Recent Filing)
JPY 0
Price to Earnings (P/E)
10.1
Beta
0.40
Next Earnings
Nov 13, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
Dec 29, 2026
Dividend Yield
5.84%

Bulls Say, Bears Say

Bulls Say

High Profitability

Sustained ~30% net margins indicate durable pricing power or cost advantage in its specialty/generic niche. High margins support ongoing reinvestment, R&D and dividend capacity, giving the company long-term earnings resilience versus lower‑margin peers.

Debt-free Balance Sheet

A zero‑debt balance sheet provides structural financial flexibility: low solvency risk, capacity to fund capex or M&A from internal resources, and resilience through industry cycles. This enhances long‑term stability and strategic optionality.

Consistent Free Cash Flow

Historically strong free cash flow conversion supports sustainable dividends, internal investment and balance sheet strength. Reliable cash generation underpins valuation-insensitive capital allocation and reduces dependence on external financing over time.

Bears Say

Deteriorating Cash Conversion (2025)

A recent drop where operating cash flow lags net income signals weaker earnings quality and potential working capital or collection stress. If persistent, this reduces free cash available for investment and dividends and raises cyclicality of reported profits.

Choppy Revenue And Margin Normalization

Volatile revenue trends and normalization from peak margins suggest less predictable top-line momentum and a reduced earnings ceiling versus prior years. This structural variability can limit durable earnings growth and complicate long‑range planning.

Declining Returns On Equity

A multi-year decline in ROE signals weakening capital efficiency—possibly from tougher market dynamics or mix shifts. Lower ROE can constrain shareholder return potential and indicate the company may need strategic action to restore past profitability levels.

4595 FAQ

What was Mizuho Medy Co., Ltd.’s price range in the past 12 months?
Mizuho Medy Co., Ltd. lowest stock price was ¥1597.00 and its highest was ¥1930.00 in the past 12 months.
What is Mizuho Medy Co., Ltd.’s market cap?
Mizuho Medy Co., Ltd.’s market cap is ¥32.59B.
When is Mizuho Medy Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Mizuho Medy Co., Ltd.’s earnings last quarter?
Mizuho Medy Co., Ltd. released its earnings results on Aug 12, 2026. The company reported ¥11.61 earnings per share for the quarter.
Is Mizuho Medy Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Mizuho Medy Co., Ltd. pay dividends?
Mizuho Medy Co., Ltd. pays a Semiannually dividend of ¥50 which represents an annual dividend yield of 5.84%. See more information on Mizuho Medy Co., Ltd. dividends here
What is Mizuho Medy Co., Ltd.’s EPS estimate?
Mizuho Medy Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mizuho Medy Co., Ltd. have?
Mizuho Medy Co., Ltd. has 19,051,200 shares outstanding.
What happened to Mizuho Medy Co., Ltd.’s price movement after its last earnings report?
Mizuho Medy Co., Ltd. reported an EPS of ¥11.61 in its last earnings report. Following the earnings report the stock price went down -0.82%.
Which hedge fund is a major shareholder of Mizuho Medy Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4595
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology